Corient Private Wealth LLC Purchases 25,468 Shares of CME Group Inc. $CME

Corient Private Wealth LLC grew its position in CME Group Inc. (NASDAQ:CME) by 20.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 153,055 shares of the financial services provider’s stock after buying an additional 25,468 shares during the quarter. Corient Private Wealth LLC’s holdings in CME Group were worth $41,815,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in CME Group in the fourth quarter worth about $27,000. Elkhorn Partners Limited Partnership bought a new position in CME Group during the 4th quarter worth about $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the 4th quarter worth about $28,000. Finally, Legacy Wealth Managment LLC ID increased its position in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the period. Institutional investors own 87.75% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Buying and Selling

In other news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent research reports. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a report on Saturday, June 13th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Raymond James Financial lifted their price objective on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, UBS Group restated an “overweight” rating on shares of CME Group in a report on Monday, June 15th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $305.18.

CME Group Stock Performance

Shares of CME Group stock opened at $246.38 on Monday. The company has a market capitalization of $89.28 billion, a PE ratio of 21.02, a P/E/G ratio of 2.75 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a 50-day simple moving average of $279.61 and a two-hundred day simple moving average of $287.27. CME Group Inc. has a one year low of $244.56 and a one year high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the business earned $2.80 EPS. The company’s revenue was up 14.5% compared to the same quarter last year. Research analysts expect that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s dividend payout ratio is presently 44.37%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.